Our Services
Medical Information
Helpful Resources
Published on: 5/13/2026
Anxiety medications such as SSRIs, SNRIs, and benzodiazepines, along with ADHD stimulants and some non-stimulants, can alter REM sleep architecture and heighten nighttime arousal, making it more likely you’ll wake during REM atonia and experience sleep paralysis.
There are several factors to consider, including medication timing, sleep hygiene, and withdrawal effects, that can influence this risk. See below for important details on how these drugs affect REM sleep and practical strategies to reduce episodes.
Sleep paralysis is a temporary inability to move or speak just as you're falling asleep or waking up. It can be unsettling, especially if you're already dealing with anxiety or ADHD. Below, we explain how certain anxiety medications and ADHD treatments might contribute to "ADHD and feeling paralyzed in bed," what the science says, and what you can do about it.
Sleep paralysis is part of a normal process during rapid eye movement (REM) sleep:
Common features include:
Up to 40% of people experience at least one episode in their lifetime, and certain factors—like anxiety disorders and stimulant use—can raise that risk.
Anxiety medications fall into a few main categories: selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and benzodiazepines. Here's how they might contribute to sleep paralysis:
SSRIs and SNRIs
Benzodiazepines
Withdrawal Effects
ADHD treatments most often include stimulant medications (e.g., methylphenidate, amphetamines) and, less commonly, non-stimulants (e.g., atomoxetine). Stimulants have several sleep-related effects:
Non-stimulant options like atomoxetine may also alter norepinephrine levels, though the impact on sleep architecture is generally milder. Still, any shift in REM timing or depth of sleep can raise the chance of waking up during REM atonia.
If you have ADHD, anxiety, or both, and you're on medication, here's why you might be more prone to sleep paralysis:
In one survey published in Sleep Medicine Reviews, individuals with psychiatric conditions reported higher rates of sleep paralysis, especially if they were on SSRIs or stimulants.
While you shouldn't stop or change any prescription without medical guidance, you can consider these strategies:
Optimize Sleep Hygiene
Adjust Medication Timing
Use Relaxation Techniques
Maintain a Sleep Diary
Sleep paralysis is usually harmless, but if you experience:
…you should speak to a doctor or sleep specialist. If you're concerned that symptoms like inattention, impulsivity, or hyperactivity might be affecting your sleep quality and daily functioning, Ubie's free AI-powered Attention Deficit Hyperactivity Disorder (ADHD) symptom checker can provide personalized insights in just a few minutes to help guide your next steps.
Important: Never stop or adjust medication without medical supervision and always consult a healthcare professional about any life-threatening or serious symptoms.
Prioritize your sleep health and consult your healthcare provider for personalized advice.
(References)
* Singh K, Jain S, Gupta R, Kumar B. Sleep paralysis and hypnagogic hallucinations in patients with anxiety disorders: a systematic review. Asian J Psychiatr. 2019 Feb;40:1-6. doi: 10.1016/j.ajp.2019.01.006. Epub 2019 Jan 10. PMID: 30678589.
* Genc E, Bayraktar F, Altin R, Ince E, Cakar E. Prevalence of sleep paralysis in patients with attention-deficit/hyperactivity disorder and narcolepsy. J Neuropsychiatry Clin Neurosci. 2019 Summer;31(3):E37-E40. doi: 10.1176/appi.neuropsych.18090205. Epub 2019 May 20. PMID: 31109007.
* Sharpless BA. Sleep paralysis: A review. Psychol Bull. 2014 Mar;140(2):482-505. doi: 10.1037/a0033580. PMID: 24589259.
* Li Y, Chen P, Li J, Liu N. The effects of antidepressants on sleep: a systematic review. J Affect Disord. 2021 Jul 15;289:15-22. doi: 10.1016/j.jad.2021.04.020. Epub 2021 Apr 22. PMID: 33917456.
* Hsieh MH, Chen YT, Su YP, Chuang HY, Lin YC, Su KP, Li CT. The impact of stimulant medications on sleep architecture in children with attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. J Affect Disord. 2023 Dec 15;343:210-219. doi: 10.1016/j.jad.2023.09.074. Epub 2023 Sep 26. PMID: 37626359.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.